Enzo Biochem Inc. (NYSE:ENZ) shares saw strong trading volume on Monday . 246,861 shares changed hands during mid-day trading, an increase of 17% from the previous session’s volume of 211,227 shares.The stock last traded at $6.03 and had previously closed at $6.36.

Separately, Zacks Investment Research downgraded Enzo Biochem from a “buy” rating to a “hold” rating in a report on Tuesday, August 9th.

The firm has a market capitalization of $271.11 million and a P/E ratio of 15.34. The firm’s 50-day moving average is $6.38 and its 200 day moving average is $5.38.

Enzo Biochem (NYSE:ENZ) last released its earnings results on Wednesday, June 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The company earned $18.16 million during the quarter, compared to analysts’ expectations of $24.50 million. During the same quarter in the previous year, the company earned ($0.07) EPS. Analysts anticipate that Enzo Biochem Inc. will post ($0.23) earnings per share for the current fiscal year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.